R J Blanch1, M S Bindra, A S Jacks, R A H Scott. 1. Academic Department of Military Surgery and Trauma, Royal Centre for Defence Medicine, Birminghame, UK. richard.blanch@tiscali.co.uk
Abstract
AIM: British military ophthalmologists have not been deployed in support of operations since 2003. Eye injuries in British forces receive definitive treatment on return to the United Kingdom. We report the injury patterns, management strategies, and outcomes for eye injuries in British Armed Forces in Iraq and Afghanistan. METHODS: Retrospective consecutive case series of eye injuries in British Armed Forces in Iraq or Afghanistan from July 2004 to May 2008. Outcomes assessed by final best-corrected visual acuity (VA; few patients lost to follow-up), rates of endophthalmitis, and proliferative vitreoretinopathy (PVR). RESULTS: There were 630 cases of major trauma, 63 sustained eye injuries (10%), and 48 sustained significant eye injuries. There were 21 open-globe injuries: 9 ruptures and perforating injuries, of which 7 were enucleated/eviscerated; 11 intraocular foreign body (IOFB) injuries, of which 1 was eviscerated. Primary repair was combined with posterior segment reconstruction in 9/11 cases with IOFB. Mean time to primary repair was 1.9 days (range 0-5). Intravitreal antibiotics were given at primary repair in five cases. All cases received early broad-spectrum systemic antibiotics. Median final VA was logMAR 0.25 excluding evisceration/enucleations. There were two cases of PVR and none of endophthalmitis. CONCLUSIONS: The number of eye injuries as a proportion of all casualties is lower than recently reported. The injuries are more severe than in civilian practise. The outcomes were comparable with previous reports, this demonstrates that, in certain cases, primary repair can be safely delayed beyond 24 h in the patient's best interests, in order to optimise the conditions for treatment.
AIM: British military ophthalmologists have not been deployed in support of operations since 2003. Eye injuries in British forces receive definitive treatment on return to the United Kingdom. We report the injury patterns, management strategies, and outcomes for eye injuries in British Armed Forces in Iraq and Afghanistan. METHODS: Retrospective consecutive case series of eye injuries in British Armed Forces in Iraq or Afghanistan from July 2004 to May 2008. Outcomes assessed by final best-corrected visual acuity (VA; few patients lost to follow-up), rates of endophthalmitis, and proliferative vitreoretinopathy (PVR). RESULTS: There were 630 cases of major trauma, 63 sustained eye injuries (10%), and 48 sustained significant eye injuries. There were 21 open-globe injuries: 9 ruptures and perforating injuries, of which 7 were enucleated/eviscerated; 11 intraocular foreign body (IOFB) injuries, of which 1 was eviscerated. Primary repair was combined with posterior segment reconstruction in 9/11 cases with IOFB. Mean time to primary repair was 1.9 days (range 0-5). Intravitreal antibiotics were given at primary repair in five cases. All cases received early broad-spectrum systemic antibiotics. Median final VA was logMAR 0.25 excluding evisceration/enucleations. There were two cases of PVR and none of endophthalmitis. CONCLUSIONS: The number of eye injuries as a proportion of all casualties is lower than recently reported. The injuries are more severe than in civilian practise. The outcomes were comparable with previous reports, this demonstrates that, in certain cases, primary repair can be safely delayed beyond 24 h in the patient's best interests, in order to optimise the conditions for treatment.
Authors: Thomas H Mader; Robert D Carroll; Clifton S Slade; Roger K George; J Phillip Ritchey; S Page Neville Journal: Ophthalmology Date: 2005-11-10 Impact factor: 12.079
Authors: D J Pieramici; P Sternberg; T M Aaberg; W Z Bridges; A Capone; J A Cardillo; E de Juan; F Kuhn; T A Meredith; W F Mieler; T W Olsen; P Rubsamen; T Stout Journal: Am J Ophthalmol Date: 1997-06 Impact factor: 5.258
Authors: Ferenc Kuhn; Richard Maisiak; LoRetta Mann; Viktória Mester; Robert Morris; C Douglas Witherspoon Journal: Ophthalmol Clin North Am Date: 2002-06
Authors: Chloe N Thomas; Ella Courtie; Alexandra Bernardo-Colón; Gareth Essex; Tonia S Rex; Zubair Ahmed; Richard J Blanch Journal: Exp Eye Res Date: 2020-06-06 Impact factor: 3.467
Authors: Christopher J Holmes; Anthony McLaughlin; Tahir Farooq; John Awad; Aidan Murray; Robert Scott Journal: Eye (Lond) Date: 2019-06-05 Impact factor: 3.775
Authors: William G Gensheimer; Kyle E Miller; Jennifer Stowe; Jeanette Little; Gary L Legault Journal: JAMA Ophthalmol Date: 2020-10-01 Impact factor: 7.389